Suggest OTCs for Seasonal Allergies Instead of Montelukast

April 2020

New boxed warnings for montelukast (Singulair) will raise questions about managing seasonal allergies...as spring ramps up.

Cases of mental health effects (depression, suicide, etc) are still being reported with montelukast...despite prior precautions.

FDA now says that montelukast's benefits may NOT outweigh risks...especially for most patients with "hay fever."

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote